Please check your internet connection and try again.
## Ecospirin (Aspirin Enteric-Coated)
### Overview
Ecospirin is an enteric-coated formulation of aspirin, a nonsteroidal anti-inflammatory drug (NSAID) that inhibits cyclooxygenase (COX) enzymes, reducing prostaglandin synthesis. The enteric coating is designed to protect the stomach lining by delaying absorption until it reaches the small intestine.
### Primary Indications
* **Cardioprotection:** Prevention of myocardial infarction (MI) and stroke in patients with established cardiovascular disease or risk factors.
* **Analgesia and Antipyresis:** Management of mild to moderate pain and fever. (Note: This is less common for enteric-coated formulations due to delayed onset).
* **Inflammation:** Management of inflammatory conditions. (Note: Higher doses are typically required, and enteric coating may affect efficacy and onset).
### Adult Dosing
* **Cardioprotection (Secondary Prevention):** 75-162 mg orally once daily.
* **Cardioprotection (Primary Prevention):** Dosing varies widely and is individualized based on risk assessment. Often 75-162 mg orally once daily. The decision to initiate primary prevention should be made in consultation with a healthcare provider.
* **Analgesia/Antipyresis/Inflammation:** Doses range from 325 mg to 650 mg every 4-6 hours as needed. Higher doses (e.g., up to 4000 mg/day) may be used for inflammatory conditions but increase the risk of toxicity. The enteric-coated formulation may not be ideal for acute pain/fever due to delayed absorption.
### Pediatric Dosing
* **Generally NOT recommended in children and adolescents <16 years of age due to the risk of Reye's syndrome.**
* **Kawasaki Disease:** Dosing varies. High-dose aspirin (80-100 mg/kg/day divided every 6 hours) may be used during the acute phase, followed by low-dose aspirin (3-5 mg/kg/day once daily) for its antiplatelet effect. Dosing should be guided by specific pediatric cardiology protocols.
### Dose Adjustments
* No specific dose adjustment for renal or hepatic impairment is routinely recommended for low-dose cardioprotective regimens. However, caution is advised in severe impairment. High-dose aspirin requires careful consideration in these populations.
### Contraindications
* Hypersensitivity to aspirin, NSAIDs, or salicylates.
* Active peptic ulceration or gastrointestinal bleeding.
* Children and adolescents with viral infections (e.g., influenza, varicella) due to the risk of Reye's syndrome.
* Severe hepatic impairment.
* Severe renal impairment.
* Asthma, urticaria, or other allergic-type reactions after taking aspirin or other NSAIDs.
* Hemophilia or other bleeding disorders.
### Adverse Effects
* **Gastrointestinal:** Dyspepsia, nausea, vomiting, abdominal pain, heartburn, occult bleeding, erosions, ulcers, perforation, hemorrhage.
* **Hematologic:** Increased bleeding time, petechiae, purpura, epistaxis, ecchymosis.
* **Hypersensitivity:** Bronchospasm, urticaria, angioedema, rash.
* **Otic:** Tinnitus, hearing loss (often dose-related).
* **Renal:** Renal insufficiency, interstitial nephritis.
* **Hepatic:** Elevated liver enzymes.
* **Reye's Syndrome:** In children and adolescents with viral illness.
### Key Drug Interactions
* **Anticoagulants (e.g., warfarin, heparin, DOACs):** Increased risk of bleeding.
* **Other NSAIDs and COX-2 inhibitors:** Additive GI toxicity and potential for reduced aspirin's cardioprotective effect if taken concurrently without proper timing.
* **Corticosteroids:** Increased risk of GI ulceration and bleeding.
* **Selective Serotonin Reuptake Inhibitors (SSRIs):** Increased risk of bleeding, particularly in the GI tract.
* **Alcohol:** Increased risk of GI irritation and bleeding.
* **Methotrexate:** May increase methotrexate toxicity.
* **Uricosuric agents (e.g., probenecid):** Aspirin may decrease the efficacy of these agents.
* **Antihypertensives:** May decrease the efficacy of some antihypertensives.
### Monitoring
* **Bleeding:** Monitor for signs and symptoms of bleeding (e.g., hematemesis, melena, hematuria, easy bruising).
* **GI Symptoms:** Assess for dyspepsia, abdominal pain, or other GI discomfort.
* **Renal Function:** Particularly in patients with pre-existing renal disease, those on concurrent nephrotoxic agents, or at high doses.
* **Hepatic Function:** Monitor if hepatic impairment is present or suspected.
* **Tinnitus/Hearing Changes:** May indicate toxicity.
### Clinical Pearls
* The enteric coating delays absorption, which can be beneficial for reducing gastric irritation but may also delay onset of action for pain or fever.
* For cardioprotection, low-dose aspirin (75-162 mg) is typically used once daily.
* If concurrent use with other NSAIDs is necessary, it's generally recommended to take the other NSAID first, then take aspirin 30 minutes to 2 hours later to minimize interference with aspirin's antiplatelet effect. Consult specific guidelines.
* Patients should be advised to avoid alcohol while taking aspirin to reduce the risk of GI bleeding.
* Discontinuation of aspirin for surgery requires careful consideration of bleeding risk versus thrombotic risk. Consult with prescribing physician and surgical team.
***
*Disclaimer: This information is intended for healthcare professionals. Always consult the most current prescribing information and relevant clinical guidelines for complete details and to verify specific dosing and safety recommendations before patient care.*
